Afya (NASDAQ:AFYA – Get Free Report)‘s stock had its “sell” rating reaffirmed by Citigroup in a research report issued on Friday,Benzinga reports. They presently have a $15.00 price target on the stock, down from their previous price target of $18.00. Citigroup’s price objective points to a potential downside of 10.93% from the stock’s current price.
AFYA has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their price objective on shares of Afya from $25.00 to $20.50 and set a “neutral” rating on the stock in a report on Friday, January 17th. The Goldman Sachs Group started coverage on Afya in a report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price target for the company. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $18.00.
View Our Latest Stock Report on AFYA
Afya Stock Up 2.8 %
Hedge Funds Weigh In On Afya
Hedge funds have recently bought and sold shares of the company. Public Employees Retirement System of Ohio bought a new position in Afya during the 3rd quarter worth approximately $34,000. Blue Trust Inc. lifted its stake in Afya by 296.9% during the fourth quarter. Blue Trust Inc. now owns 2,072 shares of the company’s stock worth $35,000 after purchasing an additional 1,550 shares during the last quarter. Quarry LP acquired a new position in Afya in the third quarter worth $75,000. Van ECK Associates Corp increased its stake in Afya by 41.9% during the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company’s stock valued at $154,000 after purchasing an additional 2,856 shares during the last quarter. Finally, Centiva Capital LP acquired a new stake in shares of Afya during the third quarter worth $213,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
- Five stocks we like better than Afya
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Commvault Systems: Share Price Primed to Vault Higher in 2025
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Unsung Beneficiaries of the Stargate Project
- Growth Stocks: What They Are, What They Are Not
- Starbucks’ CEO-Led Turnaround Gains Traction: New Highs Likely
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.